Abstract
BackgroundTo develop a novel non-invasive model for predicting clinically significant portal hypertension (CSPH) in patients with liver cirrhosis, and investigate whether carvedilol therapy could reduce the risk of hepatic decompensation...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have